Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estimating age conditional probability of developing disease from surveillance data.

Michael P Fay1

  • 1National Cancer Institute 6116 Executive Blvd, Suite 504 Bethesda, MD 20892-8317, USA. faym@mail.nih.gov

Population Health Metrics
|July 29, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adopting the estimand framework in prophylactic vaccine trials.

Vaccine·2025
Same author

15th Annual University of Pennsylvania conference on statistical issues in clinical trial/advances in time-to-event analyses in clinical trials (afternoon panel discussion).

Clinical trials (London, England)·2024
Same author

Regression Approaches to Assess Effect of Treatments That Arrest Progression of Symptoms.

Statistics in medicine·2024
Same author

Home visits versus fixed-site care by community health workers and child survival: a cluster-randomized trial, Mali.

Bulletin of the World Health Organization·2024
Same author

Infectivity of Plasmodium parasites to Aedes aegypti and Anopheles stephensi mosquitoes maintained on blood-free meals of SkitoSnack.

Parasites & vectors·2024
Same author

Visceral Leishmaniasis-Human Immunodeficiency Virus-Coinfected Patients Are Highly Infectious to Sandflies in an Endemic Area in India.

The Journal of infectious diseases·2024

This study introduces the piecewise mid-age group joinpoint (PMAJ) model to improve disease incidence rate estimation. The PMAJ model refines calculations for the age-conditional probability of developing a disease (ACPDvD), enhancing cancer modeling software.

Area of Science:

  • Biostatistics
  • Epidemiology
  • Cancer Research

Background:

  • The Fay et al. (2003) formula simplifies calculating the age-conditional probability of developing a disease for the first time (ACPDvD).
  • This formula uses rates of incidence and death per person-years alive, which are easier to estimate than rates per person-years disease-free.
  • The original Fay et al. (2003) method employed piecewise constant models for rate functions, assuming constant rates within age groups.

Purpose of the Study:

  • To detail a novel method for estimating rate functions without abrupt changes at age group boundaries.
  • To introduce the mid-age group joinpoint (MAJ) model for more flexible rate function estimation.
  • To develop a computationally faster approximation, the piecewise mid-age group joinpoint (PMAJ) model, for practical application.

Related Experiment Videos

Main Methods:

  • Developed the mid-age group joinpoint (MAJ) model for estimating disease and death rates, allowing non-constant rates within age groups.
  • Introduced the piecewise mid-age group joinpoint (PMAJ) model as a piecewise approximation to the MAJ model to enhance computational speed.
  • The PMAJ model's rates are used as input for the Fay et al. (2003) formula to estimate ACPDvD.

Main Results:

  • The MAJ model provides a more refined estimation of rate functions compared to piecewise constant models.
  • The PMAJ model offers a computationally efficient alternative to the MAJ model, enabling faster ACPDvD estimation.
  • The PMAJ model is currently implemented in the National Cancer Institute's DevCan software for ACPDvD calculations.

Conclusions:

  • The PMAJ model represents an advancement in estimating disease incidence rates for epidemiological modeling.
  • This method improves upon previous approaches by allowing for more flexible rate function estimation and faster computation.
  • The integration of the PMAJ model into DevCan software facilitates more accurate and efficient cancer risk assessment.